Screener
Ionis Pharmaceuticals IONS Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Ionis Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
FAQ
- What is Ionis Pharmaceuticals's gross margin?
- Ionis Pharmaceuticals (IONS) reported gross margin of 98.2% in Q2 2026.
- How has Ionis Pharmaceuticals's gross margin changed year-over-year?
- Ionis Pharmaceuticals's gross margin decreased by 0.7% year-over-year, from 98.9% to 98.2%.
- What is the long-term trend for Ionis Pharmaceuticals's gross margin?
- Over 5 years (2020 to 2025), Ionis Pharmaceuticals's gross margin has grown at a -0.0% compound annual growth rate (CAGR), from 98.4% to 98.3%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.
Ask your AI about Ionis Pharmaceuticals's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude